Browsing Tag
Galidesivir
4 posts
Island Pharmaceuticals (ASX: ILA) awaits FDA clearance for Galidesivir as Animal Rule review enters final phase
Island Pharmaceuticals confirms no FDA setbacks on Galidesivir. Find out what this means for its Marburg virus study and broader regulatory strategy.
Island Pharmaceuticals (ASX: ILA) targets Marburg stockpile deal after FDA greenlights Animal Rule
Island Pharmaceuticals gets FDA Animal Rule nod for Galidesivir in Marburg. Find out how it could unlock US$155M in value and stockpile contracts.
Is Island Pharmaceuticals (ASX: ILA) set for a breakout? Galidesivir awaits critical FDA decision
Island Pharmaceuticals secures FDA response timeline for Galidesivir. Find out how it may accelerate Marburg approval under the Animal Rule pathway.
Island Pharmaceuticals stock climbs as FDA clears path for Galidesivir fast-track review
Island Pharmaceuticals (ASX: ILA) stock rises as FDA fast-tracks Galidesivir under the Animal Rule, with survival data, PRV potential, and stockpile contracts in focus.